Artiva Biotherapeutics Inc (ARTV)
11.96
+0.74
(+6.60%)
USD |
NASDAQ |
Nov 05, 16:00
11.96
0.00 (0.00%)
After-Hours: 20:00
Artiva Biotherapeutics Profit Margin (Quarterly): -5.56K% for March 31, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -5.56K% |
| March 31, 2023 | -1.69K% |
| March 31, 2022 | -899.4% |
| Date | Value |
|---|---|
| December 31, 2021 | -801.1% |
| March 31, 2021 | -38.49K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-38.49K%
Minimum
Mar 2021
-801.1%
Maximum
Dec 2021
-9.49K%
Average
-1.69K%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
| NovaBay Pharmaceuticals Inc | -66.04% |
| Palatin Technologies Inc | -2.36K% |
| iBio Inc | -4.44K% |
| Theriva Biologics Inc | -- |
| Oragenics Inc | -- |
Profit Margin (Quarterly) Related Metrics
| Return on Assets | -38.54% |
| Operating Margin (Quarterly) | -5.77K% |
| Return on Net Operating Assets | -461.4% |